Xtandi
Showing 151 - 165 of 165
Castration-Resistant Prostate Cancer Trial in Worldwide (Enzalutamide, Placebo)
Completed
- Castration-Resistant Prostate Cancer
- Enzalutamide
- Placebo
-
Birmingham, Alabama
- +248 more
Nov 15, 2018
CTCs and ctDNA in Blood and Plasma Samples From Metastatic
Terminated
- Hormone-Resistant Prostate Cancer
- Metastatic Prostate Carcinoma
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Apr 13, 2017
Prostatic Tumors Trial in Trento (Docetaxel, Prednisone, Enzalutamide)
Unknown status
- Prostatic Neoplasms
- Docetaxel
- +2 more
-
Trento, ItalySanta Chiara Hospital
May 22, 2015
Prostate Cancer, Localized Prostate Cancer Trial in Baltimore (Enzalutamide, Abiraterone acetate, Prednisone)
Withdrawn
- Prostate Cancer
- Localized Prostate Cancer
- Enzalutamide
- +4 more
-
Baltimore, MarylandJohns Hopkins Hospital
Jan 22, 2015
Prostate Cancer, Pharmacokinetics of Enzalutamide Trial in United States (Enzalutamide tablet, Enzalutamide capsule)
Completed
- Prostate Cancer
- Pharmacokinetics of Enzalutamide
- Enzalutamide tablet
- Enzalutamide capsule
-
Denver, Colorado
- +3 more
Sep 8, 2014
Drug-Drug Interaction (DDI), Healthy Subjects, Pharmacokinetics of Enzalutamide Trial in Berlin (enzalutamide, rifampin)
Completed
- Drug-Drug Interaction (DDI)
- +2 more
-
Berlin, GermanyParexel International GmbH
Oct 14, 2014
Pharmacokinetics of MDV3100, Healthy Subjects, Kidney Diseases Trial in Chisinau (MDV3100)
Completed
- Pharmacokinetics of MDV3100
- +2 more
-
Chisinau, Moldova, Republic ofArensia
Sep 12, 2014
Severe Hepatic Impairment, Normal Hepatic Function Trial in Sofia (enzalutamide)
Completed
- Severe Hepatic Impairment
- Normal Hepatic Function
-
Sofia, BulgariaComac Medical Ltd.
May 12, 2014
Healthy Subjects, Pharmacokinetics of MDV3100 Trial in Zuidlaren (MDV3100)
Completed
- Healthy Subjects
- Pharmacokinetics of MDV3100
-
Zuidlaren, NetherlandsPRA International
Jul 26, 2013